Exhibit 10.2 AMENDMENT NO. 1 TO ESCROW AGREEMENT This Amendment No. 1 ("Amendment No. 1") to the Escrow Agreement dated as of November 29, 2001 (the "Agreement") is made and entered into as of November 29, 2001, by and among Endorex Corporation, a...
Exhibit 10.2
AMENDMENT NO. 1
TO
ESCROW AGREEMENT
This Amendment No. 1 ("Amendment No. 1") to the Escrow Agreement dated
as of November 29, 2001 (the "Agreement") is made and entered into as of
November 29, 2001, by and among Endorex Corporation, a Delaware corporation
("Parent"), Xxxxx X. Xxxxx, as the representative of the stockholders of
Corporate Technology Development, Inc. who are parties to the Agreement (the
"Stockholder Representative"), Paramount Capital Drug Development Holdings LLC
as a stockholder of Corporate Technology Development, Inc. (the "Stockholder"),
and Xxxxx Fargo Bank Minnesota, National Association, a national banking
association, as escrow agent (the "Escrow Agent").
RECITALS
WHEREAS, Parent, certain stockholders of Corporate Technology Development,
Inc., a Delaware corporation, the Stockholder Representative and the Escrow
Agent have entered into the Agreement; and
WHEREAS, Parent, the Stockholder Representative, the Stockholder and the
Escrow Agent desire to amend certain terms of the Agreement pursuant to Section
6.5 thereof.
AGREEMENT
NOW, THEREFORE, in consideration of the premises and the
representations, warranties, covenants and agreements contained herein and in
the Agreement and for other good and valuable consideration, the receipt of
which is hereby acknowledged, the parties hereto agree as follows:
1. Schedule C to the Agreement is hereby be amended and restated in its
entirety as set forth on Schedule 1 attached hereto.
2. All capitalized terms used but not defined herein have the meaning
ascribed to such terms in the Agreement.
3. All terms of the Agreement other than those amended hereby remain in
full force and effect.
* * * * *
IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 1
to be executed and delivered as of the date first written above.
PARENT:
ENDOREX CORPORATION
/s/ Xxxxxxx X. Xxxxx
-------------------------------
By: Xxxxxxx X. Xxxxx
---------------------------
Its: President
--------------------------
STOCKHOLDER REPRESENTATIVE:
/s/ Xxxxx X. Xxxxx
------------------------------
XXXXX X. XXXXX
ESCROW AGENT:
XXXXX FARGO BANK MINNESOTA,
NATIONAL ASSOCIATION, as Escrow Agent
/s/ Xxxxxx X. X'Xxxxxxx
-------------------------------
By: Xxxxxx X. X'Xxxxxxx
---------------------------
Title: Corporate Trust Officer
------------------------
STOCKHOLDER:
PARAMOUNT CAPITAL DRUG
DEVELOPMENT HOLDINGS LLC
/s/ Xxxxxxx Xxxxxxxxx
--------------------------------
By: Xxxxxxx Xxxxxxxxx
---------------------------
Its:
---------------------------
Schedule 1
Distributions
1. Common Stock to be distributed by the Escrow Agent to the Stockholder
Representative on or promptly after March 31, 2002 pursuant to Section 3 of
Schedule B:
----------
Stockholder Name Number of shares of Common Stock
TVM Medical Ventures GmbH & Co. KG 101,537
Nomura Bank (Switzerland) Ltd. 90,255
Xxxx Capital Partners V, L.P. 67,120
Imprimus Investors LLC 37,606
Bristol Xxxxxxxxxxx Investments, L.P. 37,606
Xxxxxxx Investments, LLC 18,803
Xxxxxxx X. Xxxxx 15,042
Xxxxx Joint Venture, L.P. 15,042
Xxxxxxx X. Xxxxxxxxx, M.D. 13,162
Concordia Partners 11,282
X. Xxxxxxxxxx-Xxxxxxx 11,282
Drax Holdings, L.P. 9,401
Xxxxxxx Xxxx 9,401
Xxxxxxx Xxxxxxxxxx 9,401
Keys Foundation, Curacro 9,401
Xxxxxx Xxxxxxxxx 7,521
Xxxxx X. Xxxxx 7,521
Xxxx Capital Partners V (Domestic Annex Fund) L.P. 5,648
Xxxxxx X. Xxxx 3,760
Caxton Partners 3,760
Xxxxxxx X. Xxxxxxxxx 3,760
The Holding Company 3,760
Seju Suzuki 3,760
Xxxxxxxxx Xxxxxxxx 3,760
Asahi Iron Foundry Co., Ltd. 3,760
Xxxxxxx Xxxxx 3,760
Maidenhair Investments, N.V. 3,760
Xxxx Capital Partners V International, L.P. 2,444
Xxxxx Xxxxx 1,880
Xxxxx Xxxx P.C. Money Purchase Plan 1,880
Xxxxx X. Xxxxxx 1,880
Xxxxx Xxxx PC Defined Benefit Pension Plan 1,880
Xxxxx X. Xxxx 1,880
Tis Prager 1,316
Xxxxx Xxxxxx 1,316
Xxxxx Xxxx, XXX (KC) 940
Xxxx Xxxxxxxxxxx 470
Paramount Capital Drug Development Holdings LLC 131,277
Xxxxx X. Xxxxxx 11,418
Xxxxxxxx Xxxxx 5,061
Xxxxxxx X. Xxxxxxx 5,061
Biotechnology Solutions, LLC 3,191
Xxxxxxxx Xxxxxxxxxxxxx 1,528
Xxxxxxx Xxxxx 1,518
Xxxxx and Xxxxx Xxxx 1,012
Huntington Street Company 1,012
June Street Company 1,012
Kash Family Foundation 810
Xxxxx X. Xxxx 713
Xxxxxxx Xxxxxxx 713
Xxxx Xxxxxxxxx 688
Xxx Xxxxxxxxx 688
Xxxxxxx Xxxxxx 607
Xxxx Xxxxxx 607
American Friends of Hebron Yeshiva in Jerusalem 202
Stockholder Name Number of shares of Common Stock
Xxxx Xxxxxxxxxxx 202
Xxxxxx X. Xxxxxxx 172
Xxxx Xxxx 172
Xxxxx X. Xxxxx 172
Xxxx X. Xxxxx 172
Xxxx Xxxxxxxx 101
Xxxxxx Xxxxx 101
Xxxxxx Xxxxxx 101
2. Common Stock to be distributed by the Escrow Agent to the Stockholder
Representative on or promptly after September 30, 2002 pursuant to Section 4
of Schedule B:
----------
Stockholder Name Number of shares of Common Stock
TVM Medical Ventures GmbH & Co. KG 50,769
Nomura Bank (Switzerland) Ltd. 45,128
Xxxx Capital Partners V, L.P. 33,560
Imprimus Investors LLC 18,803
Bristol Xxxxxxxxxxx Investments, L.P. 18,803
Xxxxxxx Investments, LLC 9,401
Xxxxxxx X. Xxxxx 7,521
Xxxxx Joint Venture, L.P. 7,521
Xxxxxxx X. Xxxxxxxxx, M.D. 6,581
Concordia Partners 5,641
X. Xxxxxxxxxx-Xxxxxxx 5,641
Drax Holdings, L.P. 4,701
Xxxxxxx Xxxx 4,701
Xxxxxxx Xxxxxxxxxx 4,701
Keys Foundation, Curacro 4,701
Xxxxxx Xxxxxxxxx 3,761
Xxxxx X. Xxxxx 3,761
Xxxx Capital Partners V (Domestic Annex Fund) L.P. 2,824
Xxxxxx X. Xxxx 1,880
Caxton Partners 1,880
Xxxxxxx X. Xxxxxxxxx 1,880
The Holding Company 1,880
Seju Suzuki 1,880
Xxxxxxxxx Xxxxxxxx 1,880
Asahi Iron Foundry Co., Ltd. 1,880
Xxxxxxx Xxxxx 1,880
Maidenhair Investments, N.V. 1,880
Xxxx Capital Partners V International, L.P. 1,222
Xxxxx Xxxxx 940
Xxxxx Xxxx P.C. Money Purchase Plan 940
Xxxxx X. Xxxxxx 940
Xxxxx Xxxx PC Defined Benefit Pension Plan 940
Xxxxx X. Xxxx 940
Tis Prager 658
Xxxxx Xxxxxx 658
Xxxxx Xxxx, XXX (KC) 470
Xxxx Xxxxxxxxxxx 235
Paramount Capital Drug Development Holdings LLC 45,550
Xxxxx X. Xxxxxx 5,709
Xxxxxxxx Xxxxx 2,530
Xxxxxxx X. Xxxxxxx 2,530
Biotechnology Solutions, LLC 1,596
Xxxxxxxx Xxxxxxxxxxxxx 764
Xxxxxxx Xxxxx 759
Xxxxx and Xxxxx Xxxx 000
Xxxxxxxxxx Xxxxxx Company 000
Xxxx Xxxxxx Company 506
Kash Family Foundation 405
Xxxxx X. Xxxx 357
Stockholder Name Number of shares of Common Stock
Xxxxxxx Xxxxxxx 357
Xxxx Xxxxxxxxx 344
Xxx Xxxxxxxxx 344
Xxxxxxx Xxxxxx 304
Xxxx Xxxxxx 304
American Friends of Hebron Yeshiva in Jerusalem 101
Xxxx Xxxxxxxxxxx 101
Xxxxxx X. Xxxxxxx 86
Xxxx Xxxx 86
Xxxxx X. Xxxxx 86
Xxxx X. Xxxxx 86
Xxxx Xxxxxxxx 50
Xxxxxx Xxxxx 00
Xxxxxx Xxxxxx 00
0. Common Stock to be distributed by the Escrow Agent to the Stockholder
Representative on or promptly after March 31, 2003 pursuant to Section 5 of
Schedule B:
----------
Stockholder Name Number of shares of Common Stock
TVM Medical Ventures GmbH & Co. KG 50,769
Nomura Bank (Switzerland) Ltd. 45,128
Xxxx Capital Partners V, L.P. 33,560
Imprimus Investors LLC 18,804
Bristol Xxxxxxxxxxx Investments, L.P. 18,804
Xxxxxxx Investments, LLC 9,402
Xxxxxxx X. Xxxxx 7,522
Xxxxx Joint Venture, L.P. 7,522
Xxxxxxx X. Xxxxxxxxx, M.D. 6,581
Concordia Partners 5,641
X. Xxxxxxxxxx-Xxxxxxx 5,641
Drax Holdings, L.P. 4,701
Xxxxxxx Xxxx 4,701
Xxxxxxx Xxxxxxxxxx 4,701
Keys Foundation, Curacro 4,701
Xxxxxx Xxxxxxxxx 3,761
Xxxxx X. Xxxxx 3,761
Xxxx Capital Partners V (Domestic Annex Fund) L.P. 2,825
Xxxxxx X. Xxxx 1,881
Caxton Partners 1,881
Xxxxxxx X. Xxxxxxxxx 1,881
The Holding Company 1,881
Seju Suzuki 1,881
Xxxxxxxxx Xxxxxxxx 1,881
Asahi Iron Foundry Co., Ltd. 1,881
Xxxxxxx Xxxxx 1,881
Maidenhair Investments, N.V. 1,881
Xxxx Capital Partners V International, L.P. 1,223
Xxxxx Xxxxx 941
Xxxxx Xxxx P.C. Money Purchase Plan 941
Xxxxx X. Xxxxxx 941
Xxxxx Xxxx PC Defined Benefit Pension Plan 941
Xxxxx X. Xxxx 941
Tis Prager 658
Xxxxx Xxxxxx 658
Xxxxx Xxxx, XXX (KC) 470
Xxxx Xxxxxxxxxxx 235
Paramount Capital Drug Development Holdings LLC 45,551
Xxxxx X. Xxxxxx 5,710
Xxxxxxxx Xxxxx 2,531
Xxxxxxx X. Xxxxxxx 2,531
Biotechnology Solutions, LLC 1,596
Xxxxxxxx Xxxxxxxxxxxxx 765
Stockholder Name Number of shares of Common Stock
Xxxxxxx Xxxxx 760
Xxxxx and Xxxxx Xxxx 000
Xxxxxxxxxx Xxxxxx Company 000
Xxxx Xxxxxx Company 506
Kash Family Foundation 405
Xxxxx X. Xxxx 357
Xxxxxxx Xxxxxxx 357
Xxxx Xxxxxxxxx 345
Xxx Xxxxxxxxx 345
Xxxxxxx Xxxxxx 304
Xxxx Xxxxxx 304
American Friends of Hebron Yeshiva in Jerusalem 102
Xxxx Xxxxxxxxxxx 102
Xxxxxx X. Xxxxxxx 86
Xxxx Xxxx 86
Xxxxx X. Xxxxx 86
Xxxx X. Xxxxx 86
Xxxx Xxxxxxxx 51
Xxxxxx Xxxxx 00
Xxxxxx Xxxxxx 51
